Sanuj K. Ravindran, MD is president and CEO of PellePharm. Dr. Ravindran also serves on the PellePharm Board of Directors, and is CEO-in-Residence with BridgeBio, PellePharm’s parent company.
PellePharm is a biotechnology company committed to targeting rare dermatologic diseases at the source. Founded by world leaders in hedgehog signaling, PellePharm is working to improve the quality of life for those suffering from Gorlin Syndrome and BCCs by providing an easy-to-use topical solution that eliminates the need for regular, painful surgeries.
